GlassScriptPhysician profile
Monique V Walcott
NPI 1508931924
$1,187.44
in general payments reported to CMS, 2019-2025
15 companies · $106 in 2025
The $106 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $114 · 2021: $130 · 2022: $145 · 2023: $182 · 2024: $131 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $369.31 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $205.33 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $179.41 | 2023-2025 | Xifaxan |
| Inari Medical, INC. | $86.64 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $54.78 | 2019-2023 | Eliquis |
| Allergan, INC. | $42.43 | 2019-2020 | |
| Novo Nordisk INC | $39.56 | 2022 | |
| Abbvie INC. | $39.34 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $36.04 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.01 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $32.17 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $19.40 | 2025 | Gvoke Hypopen |
| Mallinckrodt Hospital Products INC. | $19.29 | 2025 | Terlivaz |
| Pfizer INC. | $16.24 | 2023 | |
| Smith+Nephew, INC. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Walcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.